Matthew Mackowski Overview
- Firm
- Telegraph Hill...
- Primary Position
-
Chairman & Manag...
- Primary Industry
-
Healthcare
- Active Board Seats
-
2
- Med. Deal Size
-
- Med. Valuation
-
Matthew Mackowski General Information
Biography
Mr. Matthew Mackowski serves as Chairman & Managing Director at Telegraph Hill Partners. He served as a Board Member at Conductiv, Asuragen and Teknova. He has served on Althea Technologies' Board since 2006. He served as Board Member at TrakCel. He has been a healthcare-focused venture capital investor since 1980. He began his venture capital career with Citicorp Venture Capital, where he was VP and a member of the investment executive committee. Mr. Mackowski later joined Robertson, Stephens and Co. and was partner and Chairman of the Venture Capital Group. In 1991 he formed Mackowski and Shepler, an investment partnership focused on developing life science and medical technology companies and the predecessor to Telegraph Hill Partners (THP) where he serves as Chairman and Managing Director. He received a B.A. from Duke University and an MBA from The Wharton School.
Contact Information
Address
- 300 Montgomery Street
- Suite 1130
- San Francisco, CA 94104
- United States
Matthew Mackowski Positions (2)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Emerging Therapy Solutions | Company | Chairman of the Board, Managing Director & Partner | Bloomington, MN | Enterprise Systems (Healthcare) | |
| Telegraph Hill Partners | Investor | Chairman & Managing Director | San Francisco, CA | Venture Capital |
Matthew Mackowski Board Seats (2)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| Emerging Therapy Solutions | Enterprise Systems (Healthcare) | Privately Held (backing) | Venture Capital-Backed | Bloomington, MN | |
| Telegraph Hill Partners | San Francisco, CA |
Matthew Mackowski Lead Partner on Deals (8)
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| TrakCel | 17-Oct-2016 | Early Stage VC | Completed | Decision/Risk Analysis | Cardiff, United Kingdom | |
| Sequenom (Bioscience Business) | 30-May-2014 | Completed | Biotechnology | San Diego, CA | ||
| Conductiv (IT Consulting and Outsourcing) | 04-Oct-2010 | Completed | IT Consulting and Outsourcing | Walnut Creek, CA | ||
| Asuragen | 10-Dec-2007 | Completed | Diagnostic Equipment | Austin, TX | ||
| Althea Technologies | 09-Jan-2007 | Completed | Other Pharmaceuticals and Biotechnology | San Diego, CA | ||
| Asuragen | 01-Jun-2006 | Completed | Diagnostic Equipment | Austin, TX | ||
| Interface Associates | 31-Jan-2006 | PE Growth/Expansion | Completed | Surgical Devices | Laguna Niguel, CA | |
| Ambion | 02-May-2003 | PE Growth/Expansion | Completed | Biotechnology | Austin, TX |
Matthew Mackowski Network (123)
Board Members (46)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Ravi Nalliah | TrakCel | TrakCel | Cardiff, United Kingdom | |
| Ravi Nalliah | Emerging Therapy Solutions | Self | Bloomington, MN | |
| AltheaDx | Self | San Diego, CA | ||
| Emerging Therapy Solutions | Self | Bloomington, MN | ||
| AltheaDx | Self | San Diego, CA |
Portfolio Executives (68)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Ravi Nalliah | TrakCel | Co-Founder, Chief Strategy & Product Officer & Board Member | 17-Oct-2016 | Cardiff, United Kingdom |
| Matthew Lang | TrakCel | Chief Finance Officer | 17-Oct-2016 | Cardiff, United Kingdom |
| TrakCel | Co-Founder, Chief Executive Officer & Board Member | 17-Oct-2016 | Cardiff, United Kingdom | |
| TrakCel | Chief Operating Officer | 17-Oct-2016 | Cardiff, United Kingdom | |
| TrakCel | Vice President of Corporate Development and Strategy | 17-Oct-2016 | Cardiff, United Kingdom |
Fund Team Members (9)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| Paul Grossman Ph.D | Telegraph Hill Partners | Telegraph Hill Partners III | San Francisco, CA |
| Deval Lashkari Ph.D | Telegraph Hill Partners | Telegraph Hill Partners III | San Francisco, CA |
| Telegraph Hill Partners | San Francisco, CA | ||
| Telegraph Hill Partners | San Francisco, CA | ||
| Telegraph Hill Partners | San Francisco, CA |
Matthew Mackowski Affiliated Funds (2)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| Telegraph Hill Partners II | Telegraph Hill Partners | Venture - General | Closed | 2006 | ||||
| Telegraph Hill Partners III | Telegraph Hill Partners | Venture - General | Closed | 2013 |
Matthew Mackowski FAQs
-
Who is Matthew Mackowski?
Mr. Matthew Mackowski serves as Chairman & Managing Director at Telegraph Hill Partners.
-
How much does Matthew Mackowski typically invest?
Matthew Mackowski's median deal size is .
-
What is Matthew Mackowski’s main position?
Matthew Mackowski’s primary position is Chairman & Managing Director.
-
What are the contact details for Matthew Mackowski?
Matthew Mackowski’s email address is jm and his phone number is +1 (415) .
-
How many active board seats does Matthew Mackowski hold?
Matthew Mackowski holds 2 board seats including Emerging Therapy Solutions and Telegraph Hill Partners.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
